Safety and efficacy on TAS-102 monotherapy in clinical practice in patients with metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Kotani, Daisuke [1 ]
Shitara, Kohei [1 ]
Fukuoka, Shota [1 ]
Bando, Hideaki [1 ]
Okamoto, Wataru [1 ]
Kojima, Takashi [1 ]
Doi, Toshihiko [1 ]
Yoshino, Takayuki [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISS1-1-3
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [31] TAS-102 plus bevacizumab in metastatic colorectal cancer Reply
    Pfeiffer, Per
    Moller, Soren
    Winther, Stine Braendegaard
    Qvortrup, Camilla
    LANCET ONCOLOGY, 2020, 21 (05): : E227 - E227
  • [32] Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102
    Hamauchi, S.
    Yamazaki, K.
    Masuishi, T.
    Kito, Y.
    Komori, A.
    Tsushima, T.
    Todaka, A.
    Yokota, T.
    Machida, N.
    Fukutomi, A.
    Onozawa, Y.
    Muro, K.
    Yasui, H.
    Mori, K.
    Taniguchi, H.
    ANNALS OF ONCOLOGY, 2015, 26 : 50 - 51
  • [33] First report: A retrospective trial for evaluating the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer: HGCSG1503
    Masayoshi, Dazai
    Satoshi, Yuki
    Hiroshi, Nakatsumi
    Yasushi, Tsuji
    Yoshimitsu, Kobayashi
    Kazuteru, Hatanaka
    Hiroyuki, Okuda
    Ayumu, Hosokawa
    Koichi, Furukawa
    Kohei, Ogawa
    Shinya, Minami
    Atsushi, Ishiguro
    Takuya, Honda
    Tomoyuki, Ohta
    Kazunori, Eto
    Takashi, Kato
    Junta, Nakajima
    Takahide, Sasaki
    Michio, Nakamura
    Yoshiaki, Shindo
    Yuh, Sakata
    Yoshito, Komatsu
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Neutropenia as a predictor of efficacy in the treatment of metastatic colorectal cancer with TAS-102 (trifluridine - tipiracil).
    Rodriguez Garces, Maria Yeray
    Senin, Loreto Dominguez
    Urbano, Maria Amor
    Tarazona, Victoria Avino
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15564 - E15564
  • [35] Effectiveness of TAS-102 in patients with metastatic colorectal cancer in a single comprehensive cancer center
    Sales, C.
    Juliao, I.
    Rosinha, A.
    Marques, D.
    Carneiro, F.
    Faustino, C.
    Machado, M.
    Ferreira, P.
    Fragoso, M.
    Sousa, N.
    ANNALS OF ONCOLOGY, 2018, 29 : 79 - 79
  • [36] First report: A retrospective trial for evaluating the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer: HGCSG1503
    Yoshita, H.
    Yuki, S.
    Yagisawa, M.
    Tsuji, Y.
    Kobayashi, Y.
    Hatanaka, K.
    Okuda, H.
    Dazai, M.
    Furukawa, K.
    Ogawa, K.
    Minami, S.
    Ishiguro, A.
    Honda, T.
    Ohta, T.
    Eto, K.
    Kato, T.
    Nakajima, J.
    Sasaki, T.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Utilization of TAS-102 (TAS) or regorefenib (Rego) among commercially insured refractory metastatic colorectal cancer (R-mCRC) patients.
    Zheng, Hanke
    Yu, Tianzhou
    Romley, John
    Barzi, Afsaneh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Hospitalizations and clinical outcome in metastatic colorectal cancer during regorafenib or TAS-102 therapy
    Huemer, F.
    Piringer, G.
    Schlintl, V.
    Hackl, H.
    Rinnerthaler, G.
    Thaler, J.
    Greil, R.
    Weiss, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 128 - 128
  • [39] Therapeutic effect of TAS-102 (A) in patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard chemotherapy by the Kohne model (Km).
    Nishina, Tomohiro
    Yoshino, Takayuki
    Mizunuma, Nobuyuki
    Yamazaki, Kentaro
    Komatsu, Yoshito
    Baba, Hideo
    Tsuji, Akihito
    Yamaguchi, Kensei
    Muro, Kei
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [40] Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status
    Carriles, C.
    Jimenez-Fonseca, P.
    Sanchez-Canovas, M.
    Pimentel, P.
    Carmona-Bayonas, A.
    Garcia, T.
    Carbajales-Alvarez, M.
    Lozano-Blazquez, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (12): : 1781 - 1785
12345